Integrated Access Strategy co-creation
Our core principles are Compliancy, Confidentiality, and Keeping our promises, which guide everything we do. The objective is to support pharmaceutical companies in engaging policymakers and the public, contributing to a decision-making environment grounded in evidence and transparency.
Founder and CEO
Janno Kurg
Our services
Trizlex BioPharma primarily collaborates with policymakers and regulators, healthcare professionals and system leaders, patient and civil society organizations, key opinion leaders and academic experts, media and communication channels, and industry partners and associations.
WE IDENTIFY AND ENGAGE RELEVANT DECISION-MAKERS, INFLUENCERS, AND OPINION LEADERS
Identify and unite stakeholders based on their influence and impact to foster meaningful collaboration. Engage with decision-makers to inspire positive changes in policy directions, for the greater good. Provide tailor-made solutions that enable achievements not only for our customers’ benefit, but also for society.
We subsequently develop a comprehensive decision-maker map to guide strategic messaging and engagement activities
SYSTEMATICALLY ASSESSING DECISION-MAKERS ATTITUDES
Where appropriate, we conduct market and perception research among key stakeholders, including public officials, policymakers, medical specialists, professional associations, patient organizations, and other healthcare sector institutions
MANAGING MEDIA ENGAGEMENT AND CULTIVATING A PUBLIC CLIMATE CONDUCTIVE TO EVIDENCE-BASED DECISION-MAKING
We design and implement comprehensive media strategies, encompassing articles, press releases, opinion editorials, interviews, and expert commentary
MARKETING COMMUNICATION STRATEGIES TO ENHANCE AWARENESS
We focus on the medicine’s therapeutic indication and its societal impact, highlighting improvements in patient quality of life. Awareness and engagement are driven through the dissemination of clinical evidence, patient stories, and real-world experiences.
Communication leverages strategic channels, including seminars, conferences, face-to-face meetings, media, social platforms, and compliant partnerships with healthcare professionals and organizations
ADDITIONAL SERVICES FROM THE INTEGRATED ACCESS STARTEGY
We support reimbursement strategy and market access route analysis, develop high-quality HTA and reimbursement dossiers, and provide negotiation support to secure optimal market access outcomes with payers and authorities
PROCESS MANAGEMENT AND IMPLEMENTATION
Collaboration commences with a precise definition of objectives and identification of target audiences. A structured work plan is established, with clearly defined, measurable outcomes.
Coordination and reporting encompass regular work meetings, monthly progress reports, media monitoring, and rapid responses to public debates or draft legislation.
Comprehensive documentation ensures all activities are fully traceable and accurately reflected in reporting
LIFE-CYCLE MANAGEMENT
Support and manage brands in the late lifecycle phase (post–loss of exclusivity) to maximise their remaining medical and commercial value.
Evaluate commissioning policies and commercial access schemes, and develop evidence-based market access strategies for late-lifecycle products.
OUR PAN-BALTIC FOCUS
Media landscapes and advocacy practices vary significantly across countries; strategies that succeed in one market may not be effective in another. We collaborate with trusted partners in Estonia, Latvia, and Lithuania, leveraging their deep local expertise and knowledge of best practices within their respective policy environments.
Our approach enables us to lead initiatives locally while coordinating with regional partners and adapting strategies to country-specific contexts
